2. News
  3. BD (USA)
     Page  1 2 Next 
BD launches fully automated, high-throughput infectious disease molecular diagnostic platform in the U.S.20 May 2022
BD to invest $1.2 billion in pre-fillable syringe manufacturing over next four years Its investment includes a new manufacturing facility in Europe22 Sep 2021
BD and CerTest Biotec announce CE mark for molecular test to detect, identify certain SARS-CoV-2 variants6 Aug 2021
BD announces assay for identification of COVID-19 patients at increased relative risks of intubation3 Feb 2021
New clinical trial data demonstrates BD Libertas™ Wearable Injector as a drug delivery system10 Dec 2020
BD granted FDA 510(k) clearance for BD FACSLyric Flow Cytometer with newly integrated BD FACSDuet Sample Preparation System9 Oct 2020
BD granted FDA 510(k) clearance for BD FACSLyric Flow Cytometer with newly integrated sample preparation system6 Oct 2020
BD launches next-generation microbiology solution for liquid and non-liquid sample processing10 Aug 2020
Molecular screening test to detect antibiotic-resistant bacteria receives FDA clearance6 Nov 2019
BD launches the BD Intevia 1mL two-step disposable autoinjector22 Oct 2019